ArticleScientific reports2025
Early diagnosis of alzheimer's disease using PET imaging and deep learning with comparative data augmentation techniques.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence techniques for classification of Alzheimer's disease using neuroimaging data: a review.Frontiers in artificial intelligence · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's Disease (AD) is a neurological disorder affecting the functioning of central nervous system. It can lead to poor coordination, seizures and paralysis. Neuroimaging modalities such as Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) can provide important information about AD and will continue to do so in the future as far as clinical manifestations of this disease are concerned. Information from neuroimaging modalities can be combined with deep learning (DL) approaches to diagnose AD in its early stages, reducing the burden on neuropathologists. In this study, we compared the performances of six data augmentation methods -ellipsoidal averaging, Laplacian of Gaussian (LoG), local Laplacian, local contrast, Prewitt-edge emphasising, and unsharp masking -on AD diagnosis. We studied three binary problems: AD-Normal Control (NC), AD-Mild Cognitive Impairment (MCI), and MCI-NC, and one multiclass (3-classes) classification problem: AD-MCI-NC. We also combined these data augmentation methods and tried a strided convolution architecture for these tasks. We find that Prewitt-edge emphasising augmentation yields the best performance for AD-MCI-NC and AD-MCI classification tasks. In contrast, local Laplacian augmentation performs the best for the MCI-NC classification task, while LoG augmentation yields the best results for the AD-NC classification task.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.